1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • How I treat metastatic pancreatic cancer with emerging therapies
    Book Section

    Krantz, B. A.; O'Reilly, E. M.
    In Bekaii-Saab, T.; El-Rayes, B. F.; Pawlik, T. M. (Eds.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care (2020)

    Fulltext@MSK | Save
  • How I treat advanced hepatocellular cancer with multikinase inhibitors and other targeted therapies
    Book Section

    Mody, K.; Abou-Alfa, G. K.
    In Bekaii-Saab, T.; El-Rayes, B. F.; Pawlik, T. M. (Eds.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care (2020)

    Fulltext@MSK | Save
  • How I treat metastatic gastric and esophageal cancer with immunotherapy
    Book Section

    Chong, C. R.; Janjigian, Y. Y.
    In Bekaii-Saab, T.; El-Rayes, B. F.; Pawlik, T. M. (Eds.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care (2020)

    Fulltext@MSK | Save
  • How I treat oligometastatic colorectal cancer with adjuvant chemotherapy
    Book Section

    Cercek, A.; dos Santos Fernandes, G.
    In Bekaii-Saab, T.; El-Rayes, B. F.; Pawlik, T. M. (Eds.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care (2020)

    Fulltext@MSK | Save
  • Feasibility and clinical utility of electronic geriatric assessment (eGA) in older patients undergoing hematopoietic cell transplantation
    Meeting Abstract

    Dahi, P. B.; Lin, R. J.; Shahrokni, A.; Maloy, M. A.; Devlin, S. M.; Petrlik, E.; Ayala, J.; Brown, S.; Giralt, S. A.; Jakubowski, A. A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric cancer (mGC) with or without prior gastrectomy: Results from a phase III study (TAGS)
    Meeting Abstract

    Thuss-Patience, P.; Lorenzen, S.; Ettrich, T.; Karthaus, M.; Ilson, D. H.; Prokharau, A.; Arkenau, H. T.; Ghidini, M.; Fujitani, K.; Van Cutsem, E.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save
  • Association of PD-L1 combined positive score (CPS) and immune gene signatures with efficacy of nivolumab (NIVO) ± ipilimumab (IPI) in patients with metastatic gastroesophageal cancer (mGEC)
    Meeting Abstract

    Haag, G.; Lei, M.; Siemers, N.; Pandya, D.; Chang, H.; Sanchez, T.; Dorange, C.; Harbison, C.; Szabo, P.; Janjigian, Y.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save
  • Association of adverse events (AEs) with efficiacy outcomes for Cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase 3 CELESTIAL trial
    Meeting Abstract

    Trojan, J.; Abou-Alfa, G. K.; Meyer, T.; Cheng, A. L.; Cicin, I.; Bolondi, L.; Klümpen, H. J.; Chan, S. L.; Dadduzio, V.; Milwee, S.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save
  • Quality-adjusted life years accrued with cabozantinib in patients with advanced hepatocellular carcinoma (aHCC) in the CELESTIAL trial
    Meeting Abstract

    Trojan, J.; Abou-Alfa, G. K.; Mollon, P.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Kelley, R. K.; Baron, A. D.; Benzaghou, F.; Valcheva, V.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save
  • Safety and efficacy of 12 mg/d lenvatinib (LEN) in patients with unresectable hepatocellular carcinoma (uHCC) and bodyweight (bw) >80 kg in REFLECT
    Meeting Abstract

    Vogel, A.; Kudo, M.; Cheng, A. L.; Sung, M. W.; Finn, R. S.; Lin, A. Y.; Abou-Alfa, G. K.; Alsina, A.; Breder, V.; Tebbutt, N.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save